TECLens Secures $9.3 Million Series A Funding to Advance Its Non-Invasive Refractive Technology
STAMFORD, Connecticut – February 11, 2025 – TECLens, Inc., a clinical-stage ophthalmic medical device company, announced today it raised $9.3 million in a Series A round co-led by Johnson & Johnson Innovation – JJDC Inc. and Yonjin Capital. Other investors include Rimonci Capital, and Sunmed Capital. The funding is allocated to support the clinical development […]